Clinical Trial Update: PDO Based Drug Sensitive Test in R/M HNSCC

View source ↗

Summary

A recruiting clinical trial evaluating a patient-derived organoid–based drug sensitivity test for recurrent/metastatic head and neck squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Snippet

Sponsor: Huashan Hospital | Conditions: Head and Neck Squamous Cell Carcinoma, Patient Derived Organoid | Status: RECRUITING